Conference on Gastroenterology and Urology 2013

Los Angeles, California (PressExposure) December 29, 2012 -- OMICS Group Urology conference would be held from June 10-12, 2013 at Hilton Chicago, in the US. Eminent speakers with track record of over 200 papers are to be invited at the conference to deliver poster presentations and conduct panel discussions.

OMICS Group schedules annual events to bring professionals in Urology and Gasteroenterology to share knowledge and updates in the concerned practice from a global perspective, to international attendants.

Gastroenterology is the discipline associated with the stomach and the digestion processes. It also studies various diseases affecting the gastric system, which includes the Crohn's disease. It was addressed with the first form of through description in 1932 by Burrill Bernard Crohn.

Gastrointestinal conference features several speakers who specialize in knowledge of digestive processes, and disorders relating to the duodenum, intestine and the liver, and have an opportunity to present their findings. Australian pathologist Robin Warren, with his compatriot Barry Marshall, discovered the Helicobacter pylori bacterium that led to more insights into the peptic ulcer condition.

The C-urea breath test for ulcer detection is carried out, with patients swallowing urea that is labeled with either non-radioactive carbon-13 or radioactive carbon-14. If the urea is decomposed with the reaction, it signifies the presence of urease, the enzyme responsible for metabolizing urea that the concerned bacterium - Helicobacter pylori - uses. Gastroenterology also explores about the inflammation of the food pipe.

Ultrasonography can be used to detect upper urinary tract obstruction, and is also helpful in detecting metastases. To treat muscle-invasive bladder tumors, radical cystectomy is the standard in most countries. Carcinoma of the bladder is defined as growth of the tumor proximal to the pelvic area. Sonography of the liver and bone scan is required in certain cases. Several important prognosticators for the outcome of radiotherapy are tumor size, hydronephrosis presence, pre-radiation completeness, and transurethral bladder tumor resection (TURB).

About OMICS Publishing Group

For more details please visit our website:

Press Release Source:

Press Release Submitted On: December 29, 2012 at 8:44 am
This article has been viewed 36837 time(s).